Fuan Pharmaceutical Group Co (300194) — Financial Flexibility Index
Fuan Pharmaceutical Group Co (300194) has a Financial Flexibility Index of 0.08x as of September 2025. Free cash flow of CN¥123.08 Million (operating CF CN¥100.27 Million minus capex CN¥22.81 Million) represents 0% of total liabilities (CN¥1.51 Billion). Check 300194 PP&E to net assets ratio to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Fuan Pharmaceutical Group Co Financial Flexibility Index (2007–2024)
Historical Financial Flexibility Index trend for Fuan Pharmaceutical Group Co across 18 annual periods. See working capital position of Fuan Pharmaceutical Group Co to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Fuan Pharmaceutical Group Co (2007–2024)
Year-by-year free cash flow to debt coverage for Fuan Pharmaceutical Group Co. For the full company profile including market capitalisation, see Fuan Pharmaceutical Group Co market capitalisation.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.35x | CN¥545.38 Million | CN¥303.59 Million | CN¥1.58 Billion | ▲ +15.8% |
| 2023 | 0.30x | CN¥544.66 Million | CN¥328.98 Million | CN¥1.83 Billion | ▼ -20.3% |
| 2022 | 0.37x | CN¥722.60 Million | CN¥339.50 Million | CN¥1.93 Billion | ▲ +2.7% |
| 2021 | 0.36x | CN¥670.16 Million | CN¥257.13 Million | CN¥1.84 Billion | ▲ +1.8% |
| 2020 | 0.36x | CN¥507.09 Million | CN¥162.55 Million | CN¥1.42 Billion | ▼ -48.6% |
| 2019 | 0.70x | CN¥519.42 Million | CN¥295.63 Million | CN¥746.59 Million | ▲ +4.2% |
| 2018 | 0.67x | CN¥399.84 Million | CN¥267.68 Million | CN¥598.62 Million | ▼ -35.7% |
| 2017 | 1.04x | CN¥537.99 Million | CN¥453.37 Million | CN¥518.24 Million | ▼ -14.7% |
| 2016 | 1.22x | CN¥528.08 Million | CN¥374.16 Million | CN¥434.00 Million | ▲ +64.8% |
| 2015 | 0.74x | CN¥253.19 Million | CN¥161.03 Million | CN¥342.91 Million | ▲ +283.1% |
| 2014 | 0.19x | CN¥24.03 Million | CN¥-31.27 Million | CN¥124.69 Million | ▼ -89.8% |
| 2013 | 1.89x | CN¥261.58 Million | CN¥89.61 Million | CN¥138.47 Million | ▼ -18.5% |
| 2012 | 2.32x | CN¥195.21 Million | CN¥62.77 Million | CN¥84.20 Million | ▲ +74.4% |
| 2011 | 1.33x | CN¥165.78 Million | CN¥64.85 Million | CN¥124.69 Million | ▼ -50.4% |
| 2010 | 2.68x | CN¥174.48 Million | CN¥105.74 Million | CN¥65.09 Million | ▲ +215.3% |
| 2009 | 0.85x | CN¥93.79 Million | CN¥62.75 Million | CN¥110.31 Million | ▼ -6.7% |
| 2008 | 0.91x | CN¥83.71 Million | CN¥49.23 Million | CN¥91.83 Million | ▲ +97.5% |
| 2007 | 0.46x | CN¥33.50 Million | CN¥18.92 Million | CN¥72.58 Million | — |